MDGN-002
MDGN-002-CD-101
Phase 1 small_molecule terminated
Quick answer
MDGN-002 for Crohn Disease is a Phase 1 program (small_molecule) at Avalo Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Avalo Therapeutics
- Indication
- Crohn Disease
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated